The DOI matches its Crossref record; 146 of the 150 references it cites were found in a registry or an index.
Liver X receptors in lipid signalling and membrane homeostasis
Open accessAbstract
Liver X receptors α and β (LXRα and LXRβ) are nuclear receptors with pivotal roles in the transcriptional control of lipid metabolism. Transcriptional activity of LXRs is induced in response to elevated cellular levels of cholesterol. LXRs bind to and regulate the expression of genes that encode proteins involved in cholesterol absorption, transport, efflux, excretion and conversion to bile acids. The coordinated, tissue-specific actions of the LXR pathway maintain systemic cholesterol homeostasis and regulate immune and inflammatory responses. LXRs also regulate fatty acid metabolism by controlling the lipogenic transcription factor sterol regulatory element-binding protein 1c and regulate genes that encode proteins involved in fatty acid elongation and desaturation. LXRs exert important effects on the metabolism of phospholipids, which, along with cholesterol, are major constituents of cellular membranes. LXR activation preferentially drives the incorporation of polyunsaturated fatty acids into phospholipids by inducing transcription of the remodelling enzyme lysophosphatidylcholine acyltransferase 3. The ability of the LXR pathway to couple cellular sterol levels with the saturation of fatty acids in membrane phospholipids has implications for several physiological processes, including lipoprotein production, dietary lipid absorption and intestinal stem cell proliferation. Understanding how LXRs regulate membrane composition and function might provide new therapeutic insight into diseases associated with dysregulated lipid metabolism, including atherosclerosis, diabetes mellitus and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Liver X receptor transcription factors are key regulators of cholesterol metabolism (29, 30).”
From Aster-dependent nonvesicular transport facilitates dietary cholesterol uptake (2023) · cites this paper as [29]
In the citing paper
“Following systemic adsorption, some secondary BAs in turn impact host physiology though interaction with a variety of host nuclear receptors including FXR, liver X receptor (LXR), pregnane X receptor (PXR), and specific G-protein coupled receptors like TGR5 (Figure 1)40–44.”
From Gut microbiota and cardiovascular disease. (2020) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Macrophages in atherosclerosis: a dynamic balance
Moore, K. J., Sheedy, F. J., & Fisher, E. A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3520 · Cited by 2,559
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
Hörlein, A., Näär, A. M., Heinzel, T., Torchia, J., Gloss, B. R., Kurokawa, R., Ryan, A. K., Kamei, Y., Söderström, M., Glass, C. K., et al. (1995) · Nature · doi:10.1038/377397a0 · Cited by 2,072
Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
Altmann, S. W., Davis, H. R., Zhu, L.-J., Yao, X., Hoos, L. M., Tetzloff, G. G., Iyer, S. P. N., Maguire, M., Golovko, A., Zeng, M., et al. (2004) · Science · doi:10.1126/science.1093131 · Cited by 1,818
A transcriptional co-repressor that interacts with nuclear hormone receptors
Chen, J. D., & Evans, R. M. (1995) · Nature · doi:10.1038/377454a0 · Cited by 1,794
Cited by
Sorted by citations
Items 701–729 of 729
Altered gene expression in the liver and small intestine of horses with equine neuroaxonal dystrophy
Ryan, S. B., Durbin-Johnson, B., Woolard, K., Miller, A. D., & Finno, C. J. (2026) · Equine Veterinary Journal · doi:10.1002/evj.70216
Miao, J., Zijlstra, L. F., Heijink, M., Сидоров, И. В., van der Vaart, J. I., Müller, C., Bracher, F., de Winther, M. P. J., Giera, M. A., Neele, A. E., et al. (2026) · Steroids · doi:10.1016/j.steroids.2026.109830
Lenz, B. Q., Ankley, G. T., & Etterson, M. A. (2026) · Environmental Toxicology and Chemistry · doi:10.1093/etojnl/vgag203
MicroRNAs in metabolic syndrome and diabetes
Gupta, J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44591-0.00006-0
Cholesterol metabolism implications for cancer and therapy
Lin, L., Song, P., Xie, W., & Guo, J. (2026) · The Innovation Nutrition · doi:10.59717/j.xinn-nutri.2026.100025
Castelli, S., Aiello, G., Bruno, A. D., Fratantonio, D., Tripodi, G., Aiello, V., Lombardo, M., & Baldelli, S. (2026) · Metabolites · doi:10.3390/metabo16080533
Antoine, A., Charnay, C., Gallot, D., Minet‐Quinard, R., Marceau, G., Belville, C., Richardson, L., Blanchon, L., Menon, R., & Sapin, V. (2026) · Biomolecules · doi:10.3390/biom16081109
Yue, S. R., Zhang, X., Gong, L., Wang, C., Zhang, M., Yang, M., & Liao, F. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.120605
Shen, X., Zhen, H., Xu, C. Y., Li, Y., & Deng, Q. (2026) · Environmental Science & Technology · doi:10.1021/acs.est.6c06583
Koelblen, T., Burris, E. P., Sanders, R. K., Guin, S., Stites, R., Burris, T. P., Hayes, M. E., & Radwan, M. O. (2026) · Journal of Natural Products · doi:10.1021/acs.jnatprod.6c00484
Li, X., Wang, N., Wei, L., & Li, X. (2026) · ONCOLOGIE · doi:10.1515/oncologie-2026-0247
Yang, K., Li, J., Zhao, X., Wu, Z., & Ye, L. (2026) · Food and Chemical Toxicology · doi:10.1016/j.fct.2026.116357
Wu, L., Xue, H., Wu, Y., Shen, N., Yang, Z., Gao, L., Ma, W., & Wang, C. (2026) · Oncology Reviews · doi:10.3389/or.2026.1887460
Foglia, B., Nurcis, J., Signorini, M., Novo, E., Bocca, C., Cannito, S., & Parola, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188213
Boychenko, S. S., Dakhnevich, A., Semerikova, T., & Egorov, A. D. (2026) · Applied Biosciences · doi:10.3390/applbiosci5040084
You, C.-L., Bae, J., Jeong, Y., Leem, Y.-E., Kim, J., Park, J., Vuong, T. A., Jang, J., Park, S., Lee, Y.-S., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02935-7
Therapeutic Targeting of the LXR Pathway for Improving Myelin Integrity in Neurodegeneration
Tamhankar, S. P., Singh, M., Xavier, J., Griffett, K., & Amin, R. (2026) · Cells · doi:10.3390/cells15211928
Lee, S., Na, H.-J., Park, J. K., Kim, W. S., Seok, J., & Lee, R. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.154647
Chen, Z., Luo, Y., Xu, Y., Li, J., He, Z., Gao, Y., Liu, J., Wu, D., Qin, L., Tan, D., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1875005
Liver X receptor (LXR) signalling in macrophage inflammation and cardiometabolic disease
Zijlstra, L. F., de Winther, M. P. J., Kooijman, S., Castrillo, A., & Neele, A. E. (2026) · Cardiovascular Research · doi:10.1093/cvr/cvag214
Transcriptional regulation and function of GPR18 in macrophage subtype specification
Mena, H. A., Patsalos, A., Altomare, J., Davidsson, F., Nagy, G., Berger, W. K., Wong, B. C. K., Rahtes, A., Fredman, G., Nagy, L., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2612173123
Steroid Hormone Receptors and Signal Transduction Processes
Klinge, C. M. (2026) · Endocrinology · doi:10.1007/978-3-319-27318-1_9-2
Romero‐Ramírez, L., Díaz-Rubio, N., Arriero-Cabañero, A., & Mey, J. (2026) · Research Square · doi:10.21203/rs.3.rs-11142135/v1
She, J., Jiang, H., Gu, T., Chen, Y., Cai, J., Wei, C., Zhang, X., Tian, L., Lan, W., Qi, X., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.10.022
Yang, Y., Yu, T., Chu, Y., Liu, X., Lu, Q., TuShuai, L., & Zhang, J. (2026) · Food Frontiers · doi:10.1002/fft2.70351
BindingDB (2022) · UC San Diego · doi:10.7270/q2rb78bb
BindingDB Entry 50020440: Flindissone, a Limonoid Isolated from
BindingDB (2024) · UC San Diego · doi:10.7270/q2h70m8q
Metadata
- Authors
- Wang, B., & Tontonoz, P.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Tontonoz, Peter
- Venue
- Nature Reviews Endocrinology
- Published
- 2018-06-14
- Volume
- 14
- Issue
- 8
- Pages
- 452-463
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- PMC
- PMC6433546
- OpenAlex
- W2808548053
- Cited by
- 722
- References
- 150
- Citations by year
- 2026: 89 · 2025: 111 · 2024: 110 · 2023: 117 · 2022: 81 · 2021: 94 · 2020: 64 · 2019: 48 · 2018: 8
- FWCI
- 11.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (K01DK114373)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Lipid Membrane Structure and Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- liver X receptor, liver X receptor alpha, LXRβ, nuclear receptors, cholesterol homeostasis, lipid metabolism, SREBP-1c, fatty acid metabolism, membrane homeostasis, polyunsaturated fatty acids, bile acid synthesis, lipoprotein production, intestinal stem cell proliferation, atherosclerosis, diabetes mellitus, cancer
- MeSH terms
- Liver X Receptors, Animals, Cholesterol, Gene Expression Regulation, Homeostasis, Humans, Signal Transduction, Needs Assessment, Lipid Metabolism, Translational Research, Biomedical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
